Entity Common Stock, Shares Outstanding of IOVANCE BIOTHERAPEUTICS, INC. from 15 Aug 2011 to 13 Feb 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
IOVANCE BIOTHERAPEUTICS, INC. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 15 Aug 2011 to 13 Feb 2026.
  • IOVANCE BIOTHERAPEUTICS, INC. Entity Common Stock, Shares Outstanding for the quarter ending 13 Feb 2026 was 411,961,607.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

IOVANCE BIOTHERAPEUTICS, INC. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 411,961,607 13 Feb 2026 10-K 24 Feb 2026 2025 FY
Q3 2025 396,967,970 +92,187,180 +30% 15 Oct 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 361,853,896 +58,340,024 +19% 01 Aug 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 333,934,387 +54,101,665 +19% 30 Apr 2025 10-Q 08 May 2025 2025 Q1
Q3 2024 304,780,790 +48,862,342 +19% 01 Nov 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 303,513,872 +55,737,219 +22% 02 Aug 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 279,832,722 +55,384,168 +25% 02 May 2024 10-Q 09 May 2024 2024 Q1
Q3 2023 255,918,448 +98,077,867 +62% 30 Oct 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 247,776,653 +89,976,072 +57% 03 Aug 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 224,448,554 +67,280,233 +43% 02 May 2023 10-Q 10 May 2023 2023 Q1
Q3 2022 157,840,581 +941,463 +0.6% 26 Oct 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 157,800,581 +157,800,566 25 Jul 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 157,168,321 +4,319,039 +2.8% 25 Apr 2022 10-Q 05 May 2022 2022 Q1
Q3 2021 156,899,118 +10,211,784 +7% 26 Oct 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 15* -146,443,197 28 Jul 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 152,849,282 +25,987,702 +20% 26 Apr 2021 10-Q 06 May 2021 2021 Q1
Q3 2020 146,687,334 +20,492,419 +16% 26 Oct 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 146,443,212 +22,612,706 +18% 28 Jul 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 126,861,580 +3,347,349 +2.7% 28 Apr 2020 10-Q 05 May 2020 2020 Q1
Q3 2019 126,194,915 +3,025,387 +2.5% 31 Oct 2019 10-Q 04 Nov 2019 2019 Q3
Q2 2019 123,830,506 +28,238,337 +30% 25 Jul 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 123,514,231 +33,871,316 +38% 30 Apr 2019 10-Q 07 May 2019 2019 Q1
Q4 2018 123,420,091 13 Feb 2019 10-K 28 Feb 2019 2018 FY
Q3 2018 123,169,528 +50,536,811 +70% 31 Oct 2018 10-Q 06 Nov 2018 2018 Q3
Q2 2018 95,592,169 +32,905,634 +52% 31 Jul 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 89,642,915 +27,332,023 +44% 30 Apr 2018 10-Q 10 May 2018 2018 Q1
Q3 2017 72,632,717 +10,545,754 +17% 31 Oct 2017 10-Q 02 Nov 2017 2017 Q3
Q2 2017 62,686,535 +4,249,956 +7.3% 01 Aug 2017 10-Q 03 Aug 2017 2017 Q2
Q1 2017 62,310,892 +13,758,414 +28% 02 Mar 2017 10-K 09 Mar 2017 2016 FY
Q3 2016 62,086,963 +14,253,029 +30% 01 Nov 2016 10-Q 04 Nov 2016 2016 Q3
Q2 2016 58,436,579 +11,244,679 +24% 28 Jul 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 48,552,478 +4,470,340 +10% 30 Apr 2016 10-Q 09 May 2016 2016 Q1
Q3 2015 47,833,934 +20,194,246 +73% 31 Oct 2015 10-Q 06 Nov 2015 2015 Q3
Q2 2015 47,191,900 +19,965,550 +73% 07 Aug 2015 10-Q 10 Aug 2015 2015 Q2
Q1 2015 44,082,138 +22,023,179 +100% 16 Mar 2015 10-K 16 Mar 2015 2014 FY
Q3 2014 27,639,688 -1,481,741,506 -98% 07 Nov 2014 10-Q 13 Nov 2014 2014 Q3
Q2 2014 27,226,350 14 Aug 2014 10-Q 08 Aug 2014 2014 Q2
Q1 2014 22,058,959 31 Mar 2014 10-K 28 Mar 2014 2013 FY
Q3 2013 1,509,381,194 13 Sep 2013 10-K 23 Sep 2013 2012 FY
Q4 2012 78,293,095 +4,654,746 +6.3% 18 Jan 2013 10-Q 25 Jan 2013 2012 Q3
Q2 2012 78,293,095 14 Aug 2012 10-Q/A 10 Sep 2012 2012 Q2
Q1 2012 79,043,095 28 Mar 2012 10-K 30 Mar 2012 2011 FY
Q4 2011 73,638,349 18 Nov 2011 10-Q 21 Nov 2011 2011 Q3
Q3 2011 77,663,349 15 Aug 2011 10-Q/A 01 Sep 2011 2011 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.